Company: MYGN
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0000899923-25-000028
Chunk: 35

Company: MYRIAD GENETICS INC
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 35
---
C strive to nominate individuals with a variety of diverse backgrounds, skills, qualifications, attributes and experience such that the Board, as a group, will possess the appropriate expertise, talent and skills to fulfill its responsibilities to manage the Company in the long-term interests of the stockholders.

Board’s Disclosure of Third-Party Director and Nominee Compensation

No member of the Board has any agreement or arrangement with any person or entity other than the Company relating to compensation or other payment in connection with the director’s service as a director of the Company.

#### Management Succession Planning
The Board recognizes that ensuring continuity in senior leadership is one of its most critical responsibilities. To fulfill this duty, the Board continually oversees the development of executive talent and succession planning for senior management, including the Chief Executive Officer. The Board actively reviews and guides the creation and execution of senior management succession plans, assessing potential successors for key leadership roles and overseeing development plans for current senior management members.

As previously disclosed, on February 24, 2025, we announced that Paul J. Diaz, our President and Chief Executive Officer, will step down from those positions, and resign from the Company’s Board, effective on April 30, 2025. As part of our ongoing succession planning process, the Board had evaluated Samraat S. Raha, our current Chief Operating Officer, as a potential successor to Mr. Diaz as President and Chief Executive Officer. Following Mr. Diaz's resignation as President and Chief Executive Officer, effective April 30, 2025, the Board appointed Mr. Raha to succeed Mr. Diaz as our President and Chief Executive Officer and member of the Board, effective April 30, 2025. The Board had also evaluated Mark S. Verratti, our current Chief Commercial Officer, as a potential successor to Mr. Raha as Chief Operating Officer and determined that Mr. Verratti should succeed Mr. Raha as our Chief Operating Officer effective April 30, 2025.

#### Committees of the Board of Directors and Meetings
Meeting Attendance. During the year ended December 31, 2024, there were ten meetings of the Board. No director attended fewer than 75 percent of the total number of meetings of the Board and of each committee of the Board on which he or she served during the 2024 fiscal year. The Board has adopted a policy under which each member is encouraged, but not required to attend each annual meeting of stockholders. All members of the Board at the time of our 2024 Annual Meeting of